SAN DIEGO, Nov. 6, 2014 /PRNewswire/ — Aethlon Medical, Inc. (NASDAQ: OTCQB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, announced today that officials at Frankfurt University Hospital have reported undetectable virus in an ebola ...
Read More »Aethlon Medical Announces First Treatment of an Ebola Patient
SAN DIEGO, Oct. 14, 2014 /PRNewswire/ — Aethlon Medical, Inc. (NASDAQ: OTCQB:AEMD), announced today the first use of Hemopurifier® therapy on a patient infected with Ebola virus. The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital ...
Read More »Aethlon Medica CEO Note: A Novel Strategy To Address Ebola
AN DIEGO, Aug. 6, 2014 /PRNewswire/ — Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. The current ebola outbreak in West Africa demonstrates the urgent need for therapeutic strategies to ...
Read More »